Context.—Clinical trials have established the efficacy of antiretroviral therapy with double-
and triple-drug regimens for individuals infected with the human immunodeficiency virus (HIV)…

Results As of 30 September 2000, 106 subjects had died. Cumulative mortality was 3.9%(±0.5%)
at 12 months. In a multivariate model, after controlling for other variables that were …

Background. Achievement of a sustained virologic response (SVR) after treatment for Hepatitis
C infection is associated with improved outcomes. This meta-analysis aimed to determine …

Background The cascade of HIV care has become a focal point for implementation efforts to
maximise the individual and public health benefits of antiretroviral therapy. We aimed to …

Objective To provide population-based estimates of the prevalence of lipodystrophy syndrome
and constituent symptoms and to identify correlates of prevalent symptomology. Methods …

Background: Because of established links between entrenched poverty and risk of HIV
infection, there have long been warnings that HIV/AIDS will disproportionately affect Aboriginal …

Background: The Joint United Nations Programme on HIV/AIDS aims for HIV testing, treatment
and viral suppression rates to be 95%--95%--95% by 2025. Patented drug prices remain …

Objective: To estimate the frequency and possible predictors of patient-mediated intentional
alterations in antiretroviral medication regimens in direct response to symptoms associated …

This study provides population-based estimates of the incidence of constituent symptoms
associated with HIV-related lipodystrophy syndrome. Possible predictors of symptomatology …

Introduction ‘Repurposing’ existing drugs to treat COVID-19 is vital to reducing mortality and
controlling the pandemic. Several promising drugs have been identified and are in various …